• Home
• About us
• Our management
• Board of Directors

Board of Directors

The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.

The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.

Sir Christopher Gent - Non-Executive Chairman

Sir Christopher Gent assumed the role of Non-Executive Chairman of GlaxoSmithKline plc in January 2005 after he joined the Board as Deputy Chairman in June 2004. He holds a number of non-executive directorships and board advisory roles.
Find out more about Sir Christopher Gent

Sir Andrew Witty - Chief Executive Officer

Sir Andrew Witty assumed the role of Chief Executive Officer of GlaxoSmithKline plc in May 2008 after he joined the Board in January 2008.
Find out more about Sir Andrew Witty

Professor Sir Roy Anderson - Non-Executive Director

Professor Sir Roy Anderson joined the Board in February 2007. He is the Professor of Infectious Disease Epidemiology in the Faculty of Medicine, Imperial College, London.
Find out more about Roy Anderson

Dr Stephanie Burns - Non-Executive Director

Dr Stephanie Burns joined the Board in February 2007. She was formerly Chairman and Chief Executive Officer of Dow Corning.
Find out more about Stephanie Burns

Stacey Cartwright - Non-Executive Director

Stacey Cartwright joined the Board in April 2011. She is Executive Vice President, Chief Financial Officer of Burberry Group plc.
Find out more about Stacey Cartwright

Larry Culp - Non-Executive Director

Larry Culp joined the Board in July 2003. He is President and Chief Executive Officer of Danaher Corporation.
Find out more about Larry Culp

Sir Crispin Davis - Non-Executive Director

Sir Crispin Davis joined the Board in July 2003. He is Chairman and Director of StarBev Netherlands BV.
Find out more about Sir Crispin Davis

Simon Dingemans - Chief Financial Officer

Simon Dingemans assumed the role of Chief Financial Officer of GlaxoSmithKline plc in April 2011, after he joined the Board in January 2011.
Find out more about Simon Dingemans

Judy Lewent - Non-Executive Director

Judy Lewent joined the Board in April 2011. She is the former Executive Vice President and Chief Financial Officer of Merck & Co., Inc. and now serves on the boards of two publicly listed companies.
Find out more about Judy Lewent

Sir Deryck Maughan - Non-Executive Director

Sir Deryck Maughan joined the Board in June 2004. He is a Partner of Kohlberg Kravis Roberts and Co.
Find out more about Sir Deryck Maughan

James Murdoch - Non-Executive Director

James Murdoch joined the Board in May 2009. He is Deputy Chief Operating Officer of News Corporation.
Find out more about James Murdoch

Dr Daniel Podolsky - Non-Executive Director

Dr Daniel Podolsky joined the Board in July 2006. He is President of the University of Texas Southwestern Medical Center.
Find out more about Dr Daniel Podolsky

Dr Moncef Slaoui - Chairman, Research & Development

Dr Moncef Slaoui assumed the role of Chairman, Research & Development, GlaxoSmithKline plc, in June 2006 after he joined the Board in May 2006.
Find out more about Dr Moncef Slaoui

Tom de Swaan - Non-Executive Director

Tom de Swaan joined the Board in January 2006. He is Chairman of the Supervisory Board of Van Lanschot Bankiers.
Find out more about Tom de Swaan

Sir Robert Wilson - Non-Executive Director

Sir Robert Wilson joined the Board in November 2003 and became Senior Independent Non-Executive Director in May 2009. He is Non-Executive Chairman of BG Group plc.
Find out more about Sir Robert Wilson

Membership of board committees

• C: Chairman
• M: Member